Low 'bad' cholesterol might protect against dementia, Alzheimer's disease
Lower levels of "bad" LDL cholesterol could mean a lower risk of dementia and Alzheimer's disease, a new study says.
New blood test diagnoses Alzheimer’s disease and measures how far it's progressed
A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...
Why Alzheimer's Risk Increases With This Common Condition: New Study
People with Type 2 diabetes are at a much higher risk for Alzheimer's disease than people without diabetes, and a new stud y ...
Alzheimer’s risk rises when amount of deep sleep falls, study suggests
Not getting enough of deeper stages of sleep raises the risk of brain deterioration associated with Alzheimer’s disease, a ...
IFLScience on MSN13h
Scientists Develop Blood Test That Diagnoses Alzheimer’s And Identifies What Stage It Has Reached
Scientists have developed a blood test for Alzheimer’s disease that can help diagnose the neurodegenerative disease while ...
Alzheimer’s disease study: researchers create at-home smell test for early detection
When it comes to the early detection of Alzheimer’s disease, a new study suggests that the nose knows. Mass General Brigham neurology researchers have created a smell test that shows promise as a tool ...
An Alzheimer’s Blood Test Might Predict Advanced Disease
W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...
News Medical on MSN1h
Neuropathological basis of visual dysfunction in rare Alzheimer's forms
Differences in the distribution of certain proteins and markers in the brain may explain why some people first experience vision changes instead of memory loss in Alzheimer's disease, finds a new ...
How VR technology is changing the game for Alzheimer's disease
Most people donning virtual reality (VR) goggles are seeking the thrill of being immersed in a fictitious video game world.
How an unusual medical procedure transmitted Alzheimer’s
Knight says that the method of transmission that Collinge identified is “extremely unusual,” and there’s no evidence that ...
The US approved an Alzheimer’s drug. Seven patients subsequently died.
Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...
Alzheimer’s Association Utah: Guiding Families Through the Long Goodbye
With real help, real answers, and a 24/7 helpline, the Alzheimer’s Association Utah Chapter empowers caregivers and families ...